BioMarin Pharmaceutical Inc

BMRN(BioMarin Pharmaceutical Inc)

$57.77+1.15%

BMRN(BioMarin Pharmaceutical Inc) Price Prediction Summary

AI-Generated
As of July 1, 2026, BMRN is currently showing bullish conditions across all three analytical angles. Moving averages are cleanly aligned, MACD is positive, and sentiment indicators reflect a slight bullish bias with calls favored over puts and analyst targets implying upside; institutional ownership is strong and shorts remain modest. The convergence of technical alignment, neutral-to-bullish sentiment, and favorable structural positioning supports a near-term uptrend bias. Key uncertainty remains whether momentum can sustain without a pullback—RSI is not yet overbought, leaving room to run, but any breakdown below SMA50 at 54.64 would be a meaningful warning signal. Watch analyst target level of 87.85 as a potential intermediate resistance and monitor put/call ratio for any shift in conviction.
Technical Indicators
Short-Term Bullish

Moving averages aligned bullish, MACD positive; RSI in neutral zone suggests room for continuation.

Market Sentiment
Slightly Bullish

Put/call ratio favors calls; IV rank neutral; analyst target price implies moderate upside.

Market Structure
Strong Institutional Positioning

Institution holding over 100%, short float modest; structure favors longs.

Key Trading Levels

How Gate Predicts BMRN(BioMarin Pharmaceutical Inc) Price

Multi-Source Data Collection

Three independent data sources—technical indicators, market sentiment, and market structure signals—are integrated in real time, covering price behavior, trader behavior, and supply-demand dynamics, ensuring the analysis does not rely on a single dimension.

Independent Analysis by Dimension

Technical indicators are used to identify trends and structural positions, market sentiment is used to assess risk appetite, and market structure signals are used to identify supply-demand and positioning changes. Each dimension independently generates signals within its most appropriate time frame.

Cross-Validation of Composite Signals

When signals across multiple dimensions align, confidence in the assessment increases; when signals diverge, it indicates a transitional or consolidation phase, helping to avoid being misled by a single indicator.

Technical Indicators

AI-GeneratedAs of July 1, 2026, **BMRN technical analysis** shows a cleanly aligned moving average stack with SMA20 at 56.48 trading above SMA50 at 54.64 and SMA200 at 55.71, confirming an uptrend structure. MACD Level stands at 0.9027 with a Buy signal, indicating positive momentum convergence between the fast and slow moving averages. The RSI14 reads 59.13, positioning in the neutral zone—neither overbought nor oversold—which leaves room for further upside extension. The near-term BMRN price forecast remains supported by the bullish alignment of all three moving averages and MACD confirmation. No divergences are present; all indicators are moving in concert. Key variable to watch is whether RSI can climb above 65 without rolling over, signaling sustained buying pressure.
IndicatorValueSignal
Exponential Moving Average (10)57.1019
Buy
Exponential Moving Average (100)55.7439
Buy
Exponential Moving Average (20)56.3718
Buy
Exponential Moving Average (200)56.7341
Buy
Exponential Moving Average (30)55.9138
Buy
Exponential Moving Average (50)55.5977
Buy
Hull Moving Average (9)58.1511
Sell
Ichimoku Base Line (9, 26, 52, 26)55.9825
neutral
Moving Averages Summary
neutral
Simple Moving Average (10)56.848
Buy
Simple Moving Average (100)56.3236
Buy
Simple Moving Average (20)56.4635
Buy
Simple Moving Average (200)55.7081
Buy
Simple Moving Average (30)55.3703
Buy
Simple Moving Average (50)54.6307
Buy
Volume Weighted Moving Average (20)56.5182
Buy
Average Directional Index (14)25.6095
neutral
Awesome Oscillator2.7574
neutral
Bull Bear Power2.1061
neutral
Commodity Channel Index (20)100.4432
neutral
MACD Level (12, 26)0.8716
Buy
Momentum (10)2.68
Buy
Oscillators Summary
neutral
Relative Strength Index (14)57.8256
neutral
Stochastic %K (14, 3, 3)59.9516
neutral
Stochastic RSI Fast (3, 3, 14, 14)52.2308
neutral
Ultimate Oscillator (7, 14, 28)52.3187
neutral
Williams Percent Range (14)-35.7532
neutral
Technical Summary
neutral

Market Sentiment

AI-GeneratedAs of July 1, 2026, **BMRN market sentiment** indicators display a mild bullish lean. The put/call ratio of 0.623 suggests more call volume relative to puts, a classic bullish positioning signal that traders are betting on upside. Implied Volatility Rank at 49.29 sits near the midpoint of its one-year range, indicating neither extreme complacency nor panic—a neutral baseline for sentiment. The mean analyst target price of 87.85 implies meaningful upside from current levels, reflecting constructive expectations from the Street. The BMRN price forecast from this angle rests on sustained institutional interest and an absence of hedging panic. Sentiment remains balanced but tilted toward optimism. Watch whether put/call ratio remains below 0.70, a threshold that would signal intact bullish conviction.
Analyst Rating
87.8461
Options Put/Call Ratio
30.0700%
Implied Volatility (IV)
43.3664

Market Structure

AI-GeneratedAs of July 1, 2026, **BMRN market structure** reflects solid long-side positioning. Institutional holding ratio at 102.22\% indicates institutional buyers control more than the float—a bullish structural signal suggesting confidence from large asset managers. Short percent of float sits at a modest 6.49\%, well below danger zones, meaning shorts are not aggressively betting against the name and have limited leverage to force a squeeze. The float itself at ~192 million shares is reasonable and provides adequate liquidity. Overall, the BMRN stock outlook from a structural standpoint is favorable to longs: institutions are net buyers, short pressure is contained, and no imminent distribution from insiders is evident. The combination of over-100\% institutional ownership and low short exposure validates the bullish technical setup. Monitor whether institutional ratios stay elevated; a sharp drop would signal a shift in large-holder conviction.
Float Shares
192093806.0000
Short % of Float
0.0649
Institutional Holding
1.0213

Influencing Factors

Corporate Earnings and Profit Growth

Revenue, net profit, and forward guidance are the core factors affecting stock prices.

Industry Competition Landscape and Market Share

Changes in a company's competitiveness within the industry and its market share will impact its long-term valuation.

Overall Market Valuation and Interest Rate Environment

When interest rates rise or overall market valuations are elevated, individual stocks are more likely to experience pullbacks.

Institutional Funds and Market Sentiment

Large-scale institutional inflows or outflows, along with changes in market risk appetite, can amplify stock price volatility.

FAQ

What data is used to generate the BMRN(BioMarin Pharmaceutical Inc) price prediction?

x

BMRN(BioMarin Pharmaceutical Inc) price prediction is typically based on three types of data: technical indicators (e.g., RSI, MACD, moving averages), market sentiment (e.g., capital flows and derivatives data), and market structure signals (e.g., positioning and supply-demand changes). Multi-dimensional data is used to enhance the completeness of the analysis.

How do supply and demand affect the BMRN(BioMarin Pharmaceutical Inc) price prediction?

x

How are technical indicators used in the BMRN(BioMarin Pharmaceutical Inc) price prediction?

x

What role does market sentiment play in the BMRN(BioMarin Pharmaceutical Inc) price prediction?

x

What common factors can influence the BMRN(BioMarin Pharmaceutical Inc) price prediction?

x

How can price predictions be used to assess the current market state of BMRN(BioMarin Pharmaceutical Inc)?

x

Disclaimer

Gate only provides trade execution services. Any information, reports, opinions, comments, or other materials obtained from Gate, its employees, Gate-provided analytical tools, or third-party research do not constitute investment advice and should not be relied upon for investment decisions. You agree to do your own research and verify external information sources before making any investment. You further agree that Gate shall not be held liable for any loss or damage (including but not limited to loss of profits) arising directly or indirectly from the use of or reliance on such information. Nothing contained in any reports shall be interpreted as an explicit or implied promise, guarantee, or indication of profit, nor does it guarantee that losses can be limited or avoided. Please also note that data related to traditional finance such as forex and CFDs (e.g., real-time prices) displayed on this page is sourced from third parties, is provided for reference only, and is offered on an "as-is" basis without any representations or warranties of any kind, express or implied. Any third-party website links provided are not under Gate's control. Gate assumes no responsibility for the reliability or accuracy of such third-party websites or their content. For further details, please refer to our User Agreement.

Risk Warning

Traditional finance such as forex and CFDs may experience significant price fluctuations. Past performance is not a reliable indicator of future results. The vast majority of retail client accounts incur losses when trading forex and CFDs. Please ensure you fully understand how forex and CFDs operate and assess whether you are able to bear the risk of substantial losses. Even with stop-loss orders, your losses may exceed your initial deposit. Therefore, you should not engage in speculative trading with funds you cannot afford to lose, and you should ensure you are fully aware of the risks involved. The information provided by Gate is general in nature and does not take into account your investment objectives, financial situation, or specific needs. The content and prices on this website must not be interpreted as personal investment advice. Please ensure you fully understand the risks involved and seek independent professional advice where necessary. Gate reserves the right to terminate services at its sole discretion at any time. Gate is not liable for any losses resulting from such termination, including losses caused by closing positions at unfavorable market prices or forced liquidation. For more information, please refer to our Risk Disclosure.